DK163910C - Osmotisk praeparat til levering af en terapeutisk aktiv forbindelse med reguleret hastighed - Google Patents

Osmotisk praeparat til levering af en terapeutisk aktiv forbindelse med reguleret hastighed

Info

Publication number
DK163910C
DK163910C DK099784A DK99784A DK163910C DK 163910 C DK163910 C DK 163910C DK 099784 A DK099784 A DK 099784A DK 99784 A DK99784 A DK 99784A DK 163910 C DK163910 C DK 163910C
Authority
DK
Denmark
Prior art keywords
delivering
active connection
therapeutic active
regulated speed
osmotic preparation
Prior art date
Application number
DK099784A
Other languages
Danish (da)
English (en)
Other versions
DK99784D0 (da
DK99784A (da
DK163910B (da
Inventor
Patrick S L Wong
Brian Barclay
Joseph C Deters
Felix Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK163910(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of DK99784D0 publication Critical patent/DK99784D0/da
Publication of DK99784A publication Critical patent/DK99784A/da
Publication of DK163910B publication Critical patent/DK163910B/da
Application granted granted Critical
Publication of DK163910C publication Critical patent/DK163910C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DK099784A 1983-05-11 1984-02-24 Osmotisk praeparat til levering af en terapeutisk aktiv forbindelse med reguleret hastighed DK163910C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11
US49376083 1983-05-11

Publications (4)

Publication Number Publication Date
DK99784D0 DK99784D0 (da) 1984-02-24
DK99784A DK99784A (da) 1984-11-12
DK163910B DK163910B (da) 1992-04-21
DK163910C true DK163910C (da) 1992-09-14

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
DK099784A DK163910C (da) 1983-05-11 1984-02-24 Osmotisk praeparat til levering af en terapeutisk aktiv forbindelse med reguleret hastighed

Country Status (20)

Country Link
JP (1) JPS6041609A (enrdf_load_stackoverflow)
AT (1) AT397180B (enrdf_load_stackoverflow)
AU (1) AU566110B2 (enrdf_load_stackoverflow)
BE (1) BE898819A (enrdf_load_stackoverflow)
CA (1) CA1222950A (enrdf_load_stackoverflow)
CH (1) CH669329A5 (enrdf_load_stackoverflow)
DE (1) DE3417113A1 (enrdf_load_stackoverflow)
DK (1) DK163910C (enrdf_load_stackoverflow)
ES (1) ES532018A0 (enrdf_load_stackoverflow)
FR (1) FR2545721B1 (enrdf_load_stackoverflow)
GB (1) GB2140687B (enrdf_load_stackoverflow)
IE (1) IE56515B1 (enrdf_load_stackoverflow)
IL (1) IL71727A (enrdf_load_stackoverflow)
IT (1) IT1178911B (enrdf_load_stackoverflow)
MX (1) MX163518B (enrdf_load_stackoverflow)
NL (1) NL192250C (enrdf_load_stackoverflow)
NO (1) NO170834C (enrdf_load_stackoverflow)
NZ (1) NZ206600A (enrdf_load_stackoverflow)
SE (1) SE455918B (enrdf_load_stackoverflow)
ZA (1) ZA842422B (enrdf_load_stackoverflow)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
ES8800043A1 (es) * 1985-08-16 1987-10-16 Alza Corp Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
ATE76292T1 (de) * 1987-11-25 1992-06-15 American Cyanamid Co System fuer die verzoegerte (kontrollierte) freisetzung von substituierten dihydropyridincalciumantagonisten.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
CA2087435C (en) * 1990-08-07 1998-05-05 Scott Max Herbig Use of interfacially-polymerized membranes in delivery devices
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
JP2701977B2 (ja) * 1990-09-28 1998-01-21 ファイザー インク 疎水性媒体を含有する投薬体
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
ES2158871T3 (es) * 1993-02-23 2001-09-16 Wolfgang Dr Werner Uso de una formulacion de calcio en un medicamento para la aplicacion terapeutica a vacas lecheras que sufren hipocalcemia.
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR20030051760A (ko) * 2000-10-30 2003-06-25 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
KR101164881B1 (ko) * 2003-09-19 2012-07-23 썬 파마슈티컬 인더스트리스 리미티드 경구용 약물 전달 시스템
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (de) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
ATE502937T1 (de) 2005-10-04 2011-04-15 Bayer Schering Pharma Ag Neue polymorphe form von 5-chlor-n-(ä ( 5s )-2- 0x0-3-ä4-( 3-oxo-4-morpholinyl)-phenylü-1,3- oxazolidin-5-ylü -methyl)-2-thiophencarboxamid
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
EP2437733A4 (en) * 2009-06-02 2014-01-08 Dow Global Technologies Llc RETARD-PHARMACEUTICAL FORM
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
BR112014027618A2 (pt) 2012-05-07 2017-06-27 Bayer Pharma AG processo para a fabricação de uma forma de dosagem farmacêutica compreendendo nifedipina e candesartan cilexetil
UY34856A (es) 2012-07-03 2013-12-31 Bayer Pharma AG Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
WO2020020790A1 (de) 2018-07-24 2020-01-30 Bayer Aktiengesellschaft Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
JP2021532113A (ja) 2018-07-24 2021-11-25 バイエル・アクチエンゲゼルシヤフト 経口投与可能であり、放出を修飾した薬学的投薬形態

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE376851B (enrdf_load_stackoverflow) * 1971-01-13 1975-06-16 Alza Corp
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
IT1178911B (it) 1987-09-16
JPH0575725B2 (enrdf_load_stackoverflow) 1993-10-21
SE8402512L (sv) 1984-11-12
IE56515B1 (en) 1991-08-28
IE840010L (en) 1984-11-11
ZA842422B (en) 1984-11-28
CH669329A5 (enrdf_load_stackoverflow) 1989-03-15
NO840248L (no) 1984-11-12
JPS6041609A (ja) 1985-03-05
DE3417113C2 (enrdf_load_stackoverflow) 1989-02-02
AU566110B2 (en) 1987-10-08
IL71727A0 (en) 1984-09-30
AU2251183A (en) 1984-11-15
CA1222950A (en) 1987-06-16
NZ206600A (en) 1987-01-23
ES8503503A1 (es) 1985-03-01
SE455918B (sv) 1988-08-22
NL192250B (nl) 1996-12-02
DK99784D0 (da) 1984-02-24
DE3417113A1 (de) 1984-11-15
GB2140687A (en) 1984-12-05
AT397180B (de) 1994-02-25
GB8334189D0 (en) 1984-02-01
IT8467283A1 (it) 1985-09-23
MX163518B (es) 1992-05-25
NL8401470A (nl) 1984-12-03
NO170834C (no) 1992-12-16
DK99784A (da) 1984-11-12
NO170834B (no) 1992-09-07
IT8467283A0 (it) 1984-03-23
FR2545721A1 (fr) 1984-11-16
BE898819A (fr) 1984-05-30
IL71727A (en) 1989-01-31
NL192250C (nl) 1997-04-03
FR2545721B1 (fr) 1987-11-06
GB2140687B (en) 1987-03-18
ATA88084A (de) 1993-07-15
ES532018A0 (es) 1985-03-01
SE8402512D0 (sv) 1984-05-09
DK163910B (da) 1992-04-21

Similar Documents

Publication Publication Date Title
DK163910C (da) Osmotisk praeparat til levering af en terapeutisk aktiv forbindelse med reguleret hastighed
DK477184A (da) System til afgivelse af et terapeutisk middel i mundhulen
DK151786D0 (da) Apparat til afgivelse af befugtet gas til en patient
ES549639A0 (es) Dispositivo osmotico para la administracion controlada de unagente benefico a un ambiente de utilizacion
DK16487D0 (da) Vacciner til oral indgift
NO157869C (no) Tannholder med en anordning for befestigelse til kanten av en gravemaskinskuff e.l.
BR8602579A (pt) Metodo para produzir uma linha de irrigacao por gotejamento e emissor para linha de irrigacao por gotejamento
DK166479C (da) Anvendelse af fluoxetin, norfluoxetin eller et farmaceutisk acceptabelt salt af fluoxetin eller norfluoxetin til fremstilling af et laegemiddel med anxiolytisk virkning
DK408884A (da) Taendsats til et datterprojektil
DK246984D0 (da) Dihydrobenzopyrrolobenzodiazepiner en fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK485688D0 (da) Doseringsform til levering af diltiazem
FI841930L (fi) System foer flygplan med roterande vingar som varnar foer foer stor hoejdfoerlust efter start.
IT1204820B (it) Dispositivo perfezionata per emofiltrazione
DK467086D0 (da) Apparat til injektion af en vaeske i kaed
DK155082A (da) Fremgangsmaade til fremstilling af et praeparat med cytotoxisk virkning
GB8319546D0 (en) Pharmaceutical active salts
DK131884A (da) Farmaceutiske midler med antineoplastisk virkning
DK201884D0 (da) Farmaceutisk praeparat med anti-hypertensiv virkning
DK586284D0 (da) Quinoloncarboxylsyre-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne derivater som laegemiddel
NO864320D0 (no) Harpiksblanding istand til aa avgi et bioaktivt stoff med kontrollert hastighet.
DK620989D0 (da) Anvendelse af et prostaglandin af e-typen i kombination med cyclosporin til fremstilling af et farmaceutisk praeparat
DK249083D0 (da) Fremgangsmade til fremstilling af et pharmaceutisk praeparat til indgivelse af anti-androgent aktive forbindelser
DK348687A (da) Fremgangsmaade til fremstilling af en terapeutisk virksom forbindelse
DK163031C (da) Anvendelse af 2,6-bis-diethanol-amino-4,8-dipiperidinopyrimidooe5,4-daapyrimidin til fremstilling af et laegemiddel, der virker foroegende paa blodets indhold af lipoproteiner med stor massefylde
NL194822B (nl) Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.

Legal Events

Date Code Title Description
PUP Patent expired